Literature DB >> 8502473

ADP-ribosylation of the rhoA gene product by botulinum C3 exoenzyme causes Swiss 3T3 cells to accumulate in the G1 phase of the cell cycle.

M Yamamoto1, N Marui, T Sakai, N Morii, S Kozaki, K Ikai, S Imamura, S Narumiya.   

Abstract

Using botulinum C3 exoenzyme, which specifically ADP-ribosylates the rho gene products (rho proteins), we examined the role of these proteins in cell cycle progression in Swiss 3T3 cells. Incubation of cell lysates with C3 exoenzyme revealed a single [32P]ADP-ribosylated protein with an M(r) of 23K. This protein was identified as rhoA protein by isoelectric focusing and peptide mapping. When C3 exoenzyme was added to the culture, it ADP-ribosylated the substrate protein in the cells and reduced their growth rate and saturation density. The reduction was dependent on the amount of C3 exoenzyme and on the extent of ADP-ribosylation of the rho protein in the cells. Flow cytometric analysis of logarithmically growing cells showed that the enzyme treatment concentration-dependently accumulated the cells in the G1 phase of the cell cycle. When G1-enriched cells were treated with C3 exoenzyme and cell cycle progression initiated by the addition of serum was monitored, inhibition of G1-S transition was clearly observed. These results suggest that the rhoA gene product plays a critical role in G1-S progression in cultured Swiss 3T3 cells and that the ADP-ribosylation abolishes this activity and causes the cells to accumulate in G1 phase.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8502473

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  36 in total

1.  The golgi-associated COPI-coated buds and vesicles contain beta/gamma -actin.

Authors:  F Valderrama; A Luna; T Babía; J A Martinez-Menárguez; J Ballesta; H Barth; C Chaponnier; J Renau-Piqueras; G Egea
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

2.  RhoA biological activity is dependent on prenylation but independent of specific isoprenoid modification.

Authors:  Patricia A Solski; Whitney Helms; Patricia J Keely; Lishan Su; Channing J Der
Journal:  Cell Growth Differ       Date:  2002-08

3.  RhoE inhibits cell cycle progression and Ras-induced transformation.

Authors:  Priam Villalonga; Rosa M Guasch; Kirsi Riento; Anne J Ridley
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

4.  Cellular senescence requires CDK5 repression of Rac1 activity.

Authors:  Kamilah Alexander; Hai-Su Yang; Philip W Hinds
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

Review 5.  Multifaceted role of Rho proteins in angiogenesis.

Authors:  Sofia D Merajver; Saad Z Usmani
Journal:  J Mammary Gland Biol Neoplasia       Date:  2005-10       Impact factor: 2.673

6.  Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities.

Authors:  F M Donovan; C J Pike; C W Cotman; D D Cunningham
Journal:  J Neurosci       Date:  1997-07-15       Impact factor: 6.167

7.  Statins stimulate in vitro membrane FasL expression and lymphocyte apoptosis through RhoA/ROCK pathway in murine melanoma cells.

Authors:  Guillaume Sarrabayrouse; Cindy Synaeve; Kevin Leveque; Gilles Favre; Anne-Françoise Tilkin-Mariamé
Journal:  Neoplasia       Date:  2007-12       Impact factor: 5.715

8.  G1/S cyclin-dependent kinase regulates small GTPase Rho1p through phosphorylation of RhoGEF Tus1p in Saccharomyces cerevisiae.

Authors:  Keiko Kono; Satoru Nogami; Mitsuhiro Abe; Masafumi Nishizawa; Shinichi Morishita; David Pellman; Yoshikazu Ohya
Journal:  Mol Biol Cell       Date:  2008-02-06       Impact factor: 4.138

9.  p160ROCK mediates RhoA activation of Na-H exchange.

Authors:  T Tominaga; T Ishizaki; S Narumiya; D L Barber
Journal:  EMBO J       Date:  1998-08-17       Impact factor: 11.598

10.  Roles of insulin, guanosine 5'-[gamma-thio]triphosphate and phorbol 12-myristate 13-acetate in signalling pathways of GLUT4 translocation.

Authors:  M Todaka; H Hayashi; T Imanaka; Y Mitani; S Kamohara; K Kishi; K Tamaoka; F Kanai; M Shichiri; N Morii; S Narumiya; Y Ebina
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.